Breaking News

Thermo Fisher Introduces New Cell and Gene Therapy Services

End-to-end solution combines cryogenic and cold chain logistics, serialization compliance and global distribution.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to transition therapies from clinic to commercial launch for patients across the U.S. and Europe. The Patheon Commercial Packaging Services for Cell and Gene Therapies (CGT) is an end-to-end solution combining the GMP storage, serialization, ultracold and cryogenic packaging, and global distribution that developers need to support their logist...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters